NMR Reporter Assays for the Quantification of Weak-Affinity Receptor-Ligand Interactions

Teresa B Almeida1, Stanislava Panova1, Reto Walser1

  • 1Molecular Sciences, Astex Pharmaceuticals, Cambridge, UK.

Summary

Ligand-observed (LO) nuclear magnetic resonance (NMR) assays offer a valuable alternative to protein-observed (PO) NMR for quantifying weak molecular interactions in drug discovery, providing advantages in protein use and throughput.